2024 Full Event Guide

Browse the Full Event Guide to Discover:

  • Latest characterization methods for guides, nucleases, delivery vehicles, and full drug constructs
  • Robust non-clinical and CMC assay development, including biodistribution studies, potency assays, and on-/off- target sequencing detection, nomination, and prediction
  • How to comprehensively meet regulatory expectations for analytical data to support IND submissions
CRISPR Analytical Development

Having trouble downloading the brochure? Let us know and we’ll email it to you instead

Zak Zhang, Beam Therapeutics - CRISPR Based Therapy Analytical Development Summit

“With a broad representation from industry, academia, and regulators, I look forward to attending this year’s CRISPR-Based Therapy Analytical Development Summit and exchange ideas with peer researchers and developers.”

- Zack Zhang, Director, Analytical Development at Takeda Pharmaceuticals